Antibiotic Therapy for Klebsiella pneumoniae Bacteremia: Implications of Production of Extended-Spectrum β-Lactamases

DL Paterson, WC Ko, A Von Gottberg… - Clinical infectious …, 2004 - academic.oup.com
The prevalence of extended-spectrum β-lactamase (ESBL) production by Klebsiella
pneumonia approaches 50% in some countries, with particularly high rates in eastern …

Antibiotic therapy for Klebsiella pneumoniae bacteremia: implications of production of extended-spectrum β-lactamases

DL Paterson, WC Ko… - Clinical infectious …, 2004 - repository.uantwerpen.be
The prevalence of extended-spectrum beta-lactamase (ESBL) production by Klebsiella
pneumonia approaches 50% in some countries, with particularly high rates in eastern …

Antibiotic therapy for Klebsiella pneumoniae bacteremia: Implications of production of extended-spectrum beta-lactamases

DL Paterson, WC Ko, A Von Gottberg… - CLINICAL …, 2004 - avesis.marmara.edu.tr
The prevalence of extended-spectrum beta-lactamase (ESBL) production by Klebsiella
pneumonia approaches 50% in some countries, with particularly high rates in eastern …

[PDF][PDF] Antibiotic Therapy for Klebsiella pneumoniae Bacteremia: Implications of Production of Extended-Spectrum b-Lactamases

DL Paterson, WC Ko, A Von Gottberg… - Clinical Infectious …, 2003 - scholar.archive.org
Study design. A prospective, observational study of consecutive, sequentially encountered
patients with K. pneumoniae bacteremia was performed in 12 hospitals in South Africa …

[引用][C] Antibiotic therapy for Klebsiella pneumoniae bacteremia: Implications of production of extended-spectrum β-lactamases

DL PATERSON, WC KO, LB RICE… - Clinical infectious …, 2004 - pascal-francis.inist.fr
Antibiotic therapy for Klebsiella pneumoniae bacteremia: Implications of production of
extended-spectrum β-lactamases CNRS Inist Pascal-Francis CNRS Pascal and Francis …

Antibiotic therapy for Klebsiella pneumoniae bacteremia: implications of production of extended-spectrum β-lactamases.

DL Paterson, KWC Ko WenChien, A Gottberg… - 2004 - cabidigitallibrary.org
The prevalence of extended-spectrum β-lactamase (ESBL) production by Klebsiella
pneumoniae approaches 50% in some countries, with particularly high rates in eastern …

Antibiotic therapy for Klebsiella pneumoniae bacteremia: Implications of production of extended-spectrum β-lactamases

DL Paterson, WC Ko… - Clinical Infectious …, 2004 - researchoutput.ncku.edu.tw
The prevalence of extended-spectrum β-lactamase (ESBL) production by Klebsiella
pneumonia approaches 50% in some countries, with particularly high rates in eastern …

Antibiotic therapy for Klebsiella pneumoniae bacteremia: implications of production of extended-spectrum beta-lactamases.

DL Paterson, WC Ko, A Von Gottberg… - … Diseases: an Official …, 2004 - europepmc.org
The prevalence of extended-spectrum beta-lactamase (ESBL) production by Klebsiella
pneumonia approaches 50% in some countries, with particularly high rates in eastern …

[PDF][PDF] Antibiotic Therapy for Klebsiella pneumoniae Bacteremia: Implications of Production of Extended-Spectrum b-Lactamases

DL Paterson, WC Ko, A Von Gottberg… - Clinical Infectious …, 2003 - antimicrobe.org
Study design. A prospective, observational study of consecutive, sequentially encountered
patients with K. pneumoniae bacteremia was performed in 12 hospitals in South Africa …

Antibiotic Therapy for Klebsiella pneumoniae Bacteremia: Implications of Production of Extended-Spectrum Β-Lactamases.

DL Paterson, WC Ko, A Von Gottberg… - Clinical Infectious …, 2004 - search.ebscohost.com
The prevalence of extended-spectrum β-lactamase (ESBL) production by Klebsiella
pneumonia approaches 50% in some countries, with particularly high rates in eastern …